The Presenilin-1 DeltaE9 Mutation Results in Reduced gamma-Secretase Activity, but Not Total Loss of PS1 Function, in Isogenic Human Stem Cells.

This work use genome editing on an iPS model to demonstrate that a disease causing mutation in the Presenilin1 gene contributed to the gain of toxicity.